Core Nursing Explanation
Key Concept Analysis: This question assesses your knowledge of pre-procedure patient education for
Fluorescein Angiography, a diagnostic test for
Diabetic Retinopathy. The core theme is patient safety, specifically identifying and preventing potential allergic reactions to the contrast dye used in the procedure. The pathophysiology link is that diabetic retinopathy involves damage to the retinal blood vessels, and this test uses an intravenous dye to visualize them, which carries a risk of hypersensitivity.
Answer Rationale:
Key Point! The correct answer is to inform the healthcare provider of any allergies, especially to iodine or shellfish. While fluorescein dye is not iodine-based, this instruction is a standard and critical safety screening question. It prompts the patient to disclose any history of allergic reactions, which is essential because fluorescein sodium can cause severe reactions, including anaphylaxis. The nurse must assess for any allergy history before administering any contrast agent.
Distractor Analysis:
Watch out for confusion! Option ① (Remove jewelry) is common for procedures like MRI (Magnetic Resonance Imaging) but is not a standard or necessary precaution for fluorescein angiography, which does not involve strong magnetic fields.
Option ② (Fast for 12 hours) is incorrect. Fluorescein angiography does not require fasting. In fact, for a diabetic patient, prolonged fasting could lead to
Hypoglycemia, which is a significant safety risk.
Option ④ (Avoid bright lights) is a post-procedure instruction, not a pre-procedure one. After the test, patients may experience temporary visual disturbances and photosensitivity; they are often advised to wear sunglasses and avoid bright lights for a few hours.
Related Concepts: The nurse's role includes thorough patient assessment and education to prevent complications. For any procedure involving contrast media, allergy assessment is paramount. Diabetic patients require specific considerations to maintain glycemic control during diagnostic testing.
Concept Summary
| Concept | Key Points |
| Fluorescein Angiography | Diagnostic eye test. IV injection of fluorescein dye to photograph retinal circulation. Assesses for diabetic retinopathy, macular edema, vascular abnormalities. |
| Diabetic Retinopathy | Microvascular complication of diabetes. Damaged retinal blood vessels can leak, hemorrhage, or cause neovascularization. Leading cause of blindness in adults. |
| Pre-procedure Nursing Care | 1. Allergy assessment (primary safety step). 2. Explain procedure sensations (temporary yellow skin/urine, nausea, flushing). 3. No fasting required. 4. Obtain informed consent. |
| Post-procedure Nursing Care | 1. Monitor for allergic reaction. 2. Advise on temporary side effects (yellow vision, photosensitivity). 3. Ensure safe transportation (vision may be blurry). |
Side-by-Side Comparison!
| Procedure | Key Pre-procedure Instruction | Rationale & Common Confusion |
| Fluorescein Angiography | Report allergies (any). | Prevents anaphylaxis from dye. Not iodine-based, but allergy screening is universal. |
| CT Scan with Iodinated Contrast | Report iodine/shellfish allergies. Check renal function (Creatinine/BUN). | Prevents reaction to iodine and contrast-induced nephropathy. Often requires fasting. |
| MRI with Gadolinium Contrast | Remove all metal. Report kidney disease (GFR). | Prevents projectile injury and NSF (Nephrogenic Systemic Fibrosis). No iodine allergy link. |
Anatomy, Physiology & Pharmacology Points
- Retina: The light-sensitive layer at the back of the eye. Diabetic retinopathy damages its delicate blood vessels.
- Fluorescein Sodium: The injectable dye. It binds to plasma proteins and fluoresces under blue light, highlighting retinal vasculature. Side effects: Nausea, vomiting, urticaria, anaphylaxis (rare). It is excreted unchanged in urine, causing bright yellow discoloration for 24-48 hours.
- Pathophysiology Link: Chronic hyperglycemia → damage to capillary endothelial cells in retina → leakage (non-proliferative retinopathy) or abnormal new vessel growth (proliferative retinopathy) → vision loss.
Memory Tips
- F-L-U-O-R for Fluorescein Safety: Find Allergy history, Look out for yellow urine (post-procedure), Understand no fasting, Orient to temporary vision changes, Report nausea (common side effect).
- Think: "See the vessels, check for allergies!" The dye lets you "see" the retinal vessels, so you must first "check" for allergies to keep the patient safe.
High-Frequency NCLEX Topics
NCLEX frequently tests on
patient safety and pre-procedure preparation. For any test involving contrast dye, the #1 priority is assessing for allergies and renal function when applicable. Diabetic patient care is also a high-yield area, so integrating disease management (avoiding hypoglycemia from unnecessary fasting) with procedure prep is key.
Watch Out for Question Variations!
- Shift from "What to teach before?" to "What is the priority action if a patient develops urticaria and wheezing during the procedure?" (Answer: Stop the dye infusion, notify the provider, prepare epinephrine and emergency equipment).
- Shift to post-procedure care: "A client calls the clinic 6 hours after fluorescein angiography reporting yellow vision. What is the nurse's best response?" (Answer: Reassure the client that this is a normal, temporary side effect of the dye).